CTKB Cytek Biosciences, Inc.
Healthcare$4.01+0.00%OpenMarket Cap: $518.5M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$5.13
Target (Median)
$5.13
Target Range
$4.75 - $5.50
Upside from current price: 27.8%
Rating Distribution
1 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Stephens & Co. | maintain | Overweight | Overweight |
| 2026-05-12 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-01-08 | TD Cowen | maintain | Buy | Buy |
| 2025-11-11 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-05-28 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-0.35 | $208.8M | 1 |
| Fri Dec 31 | $-0.27 | $222.7M | 1 |
| Sun Dec 31 | $-0.23 | $245.6M | 2 |
| Mon Dec 31 | $-0.08 | $258.9M | 1 |